Posted by Michael Wonder on 13 Apr 2016
EMA publishes EPAR for Wakix
13 April 2016 - The EMA has published a European Public Assessment Report (EPAR) for Wakix (pitolisant).
An EPAR explains how the EMA assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Wakix.
Wakix is used to treat adults with narcolepsy. Because the number of patients with narcolepsy is low, the disease is considered ‘rare’, and Wakix was designated an ‘orphan medicine’ (a medicine used in rare diseases) on 10 July 2007.
For more details, go to: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002616/human_med_001955.jsp&mid=WC0b01ac058001d124
